Novartis back with bid for ‘multibillion-dollar’ Zolgensma expansion in older SMA patients as FDA lifts clinical hold

Novartis back with bid for ‘multibillion-dollar’ Zolgensma expansion in older SMA patients as FDA lifts clinical hold
aliu
Tue, 08/03/2021 – 09:37